Name: UMIN ID:
Unique ID issued by UMIN | UMIN000036856 |
---|---|
Receipt number | R000041170 |
Scientific Title | Phase II study of immunotherapy and cytotoxic agent in combination with palliative radiotherapy in patients with advanced non-small cell lung cancer |
Date of disclosure of the study information | 2019/07/05 |
Last modified on | 2023/12/03 11:42:00 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/05/26 18:20:36 | ||
2 | Update | 2019/07/04 14:32:11 | Date of disclosure of the study information |
|
3 | Update | 2019/07/04 14:33:00 | Anticipated trial start date |
|
4 | Update | 2019/11/29 13:17:04 | Recruitment status Date of IRB |
|
5 | Update | 2023/05/29 17:19:34 | Recruitment status |
|
6 | Update | 2023/12/03 11:42:00 | Number of participants that the trial has enrolled |